Semi-Annual Consolidated Statement Of Income

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7256194

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Semi-annual consolidated statement of income
Statement of income
Net sales
JPY
64,139,000,000 JPY
325,000,000 JPY
56,655,000,000 JPY
7,246,000,000 JPY
64,227,000,000 JPY
-88,000,000 JPY
56,016,000,000 JPY
226,000,000 JPY
-64,000,000 JPY
62,843,000,000 JPY
62,907,000,000 JPY
6,664,000,000 JPY
Cost of sales
32,803,000,000 JPY
32,178,000,000 JPY
Ordinary profit (loss)
5,107,000,000 JPY
3,191,000,000 JPY
2,467,000,000 JPY
6,522,000,000 JPY
Gross profit (loss)
31,335,000,000 JPY
30,664,000,000 JPY
Selling, general and administrative expenses
Amortization of goodwill
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Selling, general and administrative expenses
26,003,000,000 JPY
24,164,000,000 JPY
Extraordinary income
1,384,000,000 JPY
3,340,000,000 JPY
Extraordinary losses
300,000,000 JPY
JPY
Profit (loss) before income taxes
6,192,000,000 JPY
3,191,000,000 JPY
2,467,000,000 JPY
9,862,000,000 JPY
Operating profit (loss)
JPY
5,331,000,000 JPY
2,000,000 JPY
3,188,000,000 JPY
6,349,000,000 JPY
300,000,000 JPY
6,652,000,000 JPY
-1,321,000,000 JPY
7,647,000,000 JPY
-125,000,000 JPY
-1,216,000,000 JPY
2,499,000,000 JPY
6,500,000,000 JPY
7,717,000,000 JPY
195,000,000 JPY
Non-operating income
Interest income
6,000,000 JPY
4,000,000 JPY
Dividend income
286,000,000 JPY
330,000,000 JPY
Non-operating income
398,000,000 JPY
12,000,000 JPY
6,000,000 JPY
414,000,000 JPY
Income taxes - current
750,000,000 JPY
29,000,000 JPY
3,000,000 JPY
3,514,000,000 JPY
Income taxes - deferred
341,000,000 JPY
-1,000,000 JPY
-2,000,000 JPY
-1,197,000,000 JPY
Non-operating expenses
Interest expenses
51,000,000 JPY
5,000,000 JPY
3,000,000 JPY
40,000,000 JPY
Share of loss of entities accounted for using equity method
53,000,000 JPY
41,000,000 JPY
Non-operating expenses
622,000,000 JPY
9,000,000 JPY
38,000,000 JPY
392,000,000 JPY
Income taxes
1,091,000,000 JPY
28,000,000 JPY
1,000,000 JPY
2,316,000,000 JPY
Extraordinary income
Profit (loss)
3,163,000,000 JPY
5,101,000,000 JPY
3,163,000,000 JPY
3,163,000,000 JPY
3,163,000,000 JPY
2,466,000,000 JPY
2,466,000,000 JPY
2,466,000,000 JPY
7,545,000,000 JPY
2,466,000,000 JPY
Extraordinary losses
Impairment losses
300,000,000 JPY
JPY
Profit (loss) attributable to owners of parent
5,101,000,000 JPY
5,101,000,000 JPY
5,101,000,000 JPY
7,545,000,000 JPY
7,545,000,000 JPY
7,545,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
60,000,000 JPY
202,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-167,000,000 JPY
362,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
228,000,000 JPY
16,000,000 JPY
Other comprehensive income
121,000,000 JPY
581,000,000 JPY
Comprehensive income
5,222,000,000 JPY
8,127,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
5,222,000,000 JPY
8,127,000,000 JPY
Profit attributable to

Talk to a Data Expert

Have a question? We'll get back to you promptly.